Anti-TNF-alpha therapies: the next generation - PubMed (original) (raw)
Review
doi: 10.1038/nrd1175.
Affiliations
- PMID: 12951580
- DOI: 10.1038/nrd1175
Review
Anti-TNF-alpha therapies: the next generation
Michael A Palladino et al. Nat Rev Drug Discov. 2003 Sep.
Abstract
The functioning of the immune system is finely balanced by the activities of pro-inflammatory and anti-inflammatory mediators or cytokines. Unregulated activities of these mediators can lead to the development of serious inflammatory diseases. In particular, enhanced tumour-necrosis factor-alpha (TNF-alpha) synthesis is associated with the development of rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Inhibiting TNF-alpha activities in these diseases has been remarkably successful. However, the current injectable protein therapies have associated risks and limitations. An oral, small molecule that regulates TNF-alpha biology could either replace the injectables or provide better disease control when used alone or in conjunction with existing therapies. In this review, we discuss briefly the present understanding of TNF-alpha-mediated biology and the current injectable therapies in clinical use, and focus on some of the new therapeutic approaches with oral, small-molecule inhibitors.
Similar articles
- Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases.
Holtmann MH, Schütz M, Galle PR, Neurath MF. Holtmann MH, et al. Z Gastroenterol. 2002 Aug;40(8):587-600. doi: 10.1055/s-2002-33418. Z Gastroenterol. 2002. PMID: 12297983 Review. - Modulating TNF-alpha signaling with natural products.
Paul AT, Gohil VM, Bhutani KK. Paul AT, et al. Drug Discov Today. 2006 Aug;11(15-16):725-32. doi: 10.1016/j.drudis.2006.06.002. Drug Discov Today. 2006. PMID: 16846800 Review. - Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB. Mäki-Petäjä KM, et al. Circulation. 2006 Sep 12;114(11):1185-92. doi: 10.1161/CIRCULATIONAHA.105.601641. Epub 2006 Sep 4. Circulation. 2006. PMID: 16952987 Clinical Trial. - [Anti-TNF alpha in dermatology].
Mahe E, Descamps V. Mahe E, et al. Ann Dermatol Venereol. 2002 Dec;129(12):1374-9. Ann Dermatol Venereol. 2002. PMID: 12536174 Review. French. - Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J, Segal I. Kurtovic J, et al. Trop Gastroenterol. 2004 Jan-Mar;25(1):9-14. Trop Gastroenterol. 2004. PMID: 15303463 Review.
Cited by
- Deep learning of multimodal networks with topological regularization for drug repositioning.
Ohnuki Y, Akiyama M, Sakakibara Y. Ohnuki Y, et al. J Cheminform. 2024 Aug 23;16(1):103. doi: 10.1186/s13321-024-00897-y. J Cheminform. 2024. PMID: 39180095 Free PMC article. - Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries.
Pocino K, Carnazzo V, Stefanile A, Basile V, Guerriero C, Marino M, Rigante D, Basile U. Pocino K, et al. Int J Mol Sci. 2024 Jul 16;25(14):7762. doi: 10.3390/ijms25147762. Int J Mol Sci. 2024. PMID: 39063004 Free PMC article. Review. - Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity.
Sahu D, Gupta C, Yennamalli RM, Sharma S, Roy S, Hasan S, Gupta P, Sharma VK, Kashyap S, Kumar S, Dwivedi VP, Zhao X, Panda AK, Das HR, Liu CJ. Sahu D, et al. Sci Rep. 2024 Jun 5;14(1):12935. doi: 10.1038/s41598-024-63790-6. Sci Rep. 2024. PMID: 38839973 Free PMC article. - TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers.
Damhofer H, Tatar T, Southgate B, Scarneo S, Agger K, Shlyueva D, Uhrbom L, Morrison GM, Hughes PF, Haystead T, Pollard SM, Helin K. Damhofer H, et al. Cell Death Dis. 2024 Apr 17;15(4):273. doi: 10.1038/s41419-024-06654-1. Cell Death Dis. 2024. PMID: 38632238 Free PMC article. - Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer.
Florescu DN, Boldeanu MV, Șerban RE, Florescu LM, Serbanescu MS, Ionescu M, Streba L, Constantin C, Vere CC. Florescu DN, et al. Life (Basel). 2023 Nov 27;13(12):2261. doi: 10.3390/life13122261. Life (Basel). 2023. PMID: 38137862 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources